Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
OTLK
Outlook Therapeutics, Inc.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$0.57
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$139.62M
RECENT INSIDER TRADES
2026-08-14
· Jahr Robert Charles
(Chief Executive Officer)
· BUY
2026-08-14
· KENYON LAWRENCE A
(Chief Financial Officer)
· BUY
2026-08-14
· Sukhtian Ghiath M.
(Director)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
73
Shares held
22,367,335
Value
$38.11M
Percent of shares outstanding
9.19%
As of quarter end
2026-06-30
RECENT NEWS
Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
Outlook Therapeutics submits HCPCS application for LYTENAVA J-Code
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Outlook Therapeutics, Inc. (OTLK) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit